a phase ii trial of combination chemotherapy with mitoxantrone , cisplatin , and methyl-glyoxal bix-guanylhydrazone ( mgbg ) was conducted in 32 patients with unfavorable histology malignant lymphoma .
C0026259
mitoxantrone
C0024299
malignant lymphoma